Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.

Alvarez-Lajonchere L, Dueñas-Carrera S.

Int Rev Immunol. 2012 Jun;31(3):223-42. doi: 10.3109/08830185.2012.680552. Review.

PMID:
22587022
2.

Studies of hepatitis C virus in chimpanzees and their importance for vaccine development.

Bukh J, Forns X, Emerson SU, Purcell RH.

Intervirology. 2001;44(2-3):132-42. Review.

PMID:
11509874
3.

Development of a heterologous, multigenotype vaccine against hepatitis C virus infection.

Encke J, Radunz W, Eisenbach C, Geib J, Gehrke S, Pfaff E, Stremmel W.

Eur J Clin Invest. 2007 May;37(5):396-406.

PMID:
17461986
4.

Prospects for a vaccine against the hepatitis C virus.

Houghton M, Abrignani S.

Nature. 2005 Aug 18;436(7053):961-6. Review.

PMID:
16107836
5.

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.

Forns X, Payette PJ, Ma X, Satterfield W, Eder G, Mushahwar IK, Govindarajan S, Davis HL, Emerson SU, Purcell RH, Bukh J.

Hepatology. 2000 Sep;32(3):618-25.

PMID:
10960458
6.

Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees.

Barth H, Rybczynska J, Patient R, Choi Y, Sapp RK, Baumert TF, Krawczynski K, Liang TJ.

Hepatology. 2011 Oct;54(4):1135-48. doi: 10.1002/hep.24489. Epub 2011 Aug 11.

7.

CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus.

Puig M, Mihalik K, Tilton JC, Williams O, Merchlinsky M, Connors M, Feinstone SM, Major ME.

Hepatology. 2006 Sep;44(3):736-45.

PMID:
16941702
8.

A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.

Zeng R, Li G, Ling S, Zhang H, Yao Z, Xiu B, He F, Huang R, Wei L.

Antiviral Res. 2009 Oct;84(1):23-30. doi: 10.1016/j.antiviral.2009.07.011. Epub 2009 Jul 29.

PMID:
19646486
9.

Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.

Torresi J, Johnson D, Wedemeyer H.

J Hepatol. 2011 Jun;54(6):1273-85. doi: 10.1016/j.jhep.2010.09.040. Epub 2011 Jan 12. Review.

10.

Advances in DNA immunization against hepatitis C virus infection.

Alvarez-Lajonchere L, Dueñas-Carrera S.

Hum Vaccin. 2009 Aug;5(8):568-71.

PMID:
19736511
11.

Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine.

Thimme R, Neumann-Haefelin C, Boettler T, Blum HE.

Biol Chem. 2008 May;389(5):457-67. Review.

PMID:
18953713
12.

Neutralising antibody, CTL and dendritic cell responses to hepatitis C virus: a preventative vaccine strategy.

Torresi J, Bharadwaj M, Jackson DC, Gowans EJ.

Curr Drug Targets. 2004 Jan;5(1):41-56. Review.

PMID:
14738217
14.

Progress toward development of a hepatitis C vaccine with broad shoulders.

Ray R.

Sci Transl Med. 2011 Aug 3;3(94):94ps33. doi: 10.1126/scitranslmed.3002772.

PMID:
21813753
15.

Development of a hepatitis C virus vaccine.

Inchauspé G, Feinstone S.

Clin Liver Dis. 2003 Feb;7(1):243-59, xi. Review.

PMID:
12691469
16.

Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses.

Houghton M.

Immunol Rev. 2011 Jan;239(1):99-108. doi: 10.1111/j.1600-065X.2010.00977.x. Review.

PMID:
21198667
17.

Success and failure of virus-specific T cell responses in hepatitis C virus infection.

Neumann-Haefelin C, Thimme R.

Dig Dis. 2011;29(4):416-22. doi: 10.1159/000329807. Epub 2011 Aug 30. Review.

PMID:
21894013
18.

Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.

Feinstone SM, Hu DJ, Major ME.

Clin Infect Dis. 2012 Jul;55 Suppl 1:S25-32. doi: 10.1093/cid/cis362. Review.

PMID:
22715210
19.

[The development of therapeutic vaccine for hepatitis C virus].

Kimura K, Kohara M.

Gan To Kagaku Ryoho. 2012 Oct;39(10):1451-7. Review. Japanese.

PMID:
23064054
20.

Expression, purification, immunological characterization and application of Escherichia coli-derived hepatitis C virus E2 proteins.

Liu J, Zhu L, Zhang X, Lu M, Kong Y, Wang Y, Li G.

Biotechnol Appl Biochem. 2001 Oct;34(Pt 2):109-19.

PMID:
11592917

Supplemental Content

Support Center